• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

平行、AA/BB、AB/BA与巴兰设计:混合效应线性回归中检验治疗效果时的高效与极大极小选择

Parallel, AA/BB, AB/BA and Balaam's design: efficient and maximin choices when testing the treatment effect in a mixed effects linear regression.

作者信息

Candel Math J J M

机构信息

Department Methodology and Statistics, Maastricht University, Maastricht, The Netherlands.

出版信息

Pharm Stat. 2012 Mar-Apr;11(2):97-106. doi: 10.1002/pst.502. Epub 2012 Feb 15.

DOI:10.1002/pst.502
PMID:22337606
Abstract

When examining the effect of treatment A versus B, there may be a choice between a parallel group design, an AA/BB design, an AB/BA cross-over and Balaam's design. In case of a linear mixed effects regression, it is examined, starting from a flexible function of the costs involved and allowing for subject dropout, which design is most efficient in estimating this effect. For no carry-over, the AB/BA cross-over design is most efficient as long as the dropout rate at the second measurement does not exceed 2ρ/(1 + ρ), ρ being the intraclass correlation. For steady-state carry-over, depending on the costs involved, the dropout rate and ρ, either a parallel design or an AA/BB design is most efficient. For types of carry-over that allow for self carry-over, interest is in the direct treatment effect plus the self carry-over effect, with either an AA/BB or Balaam's design being most efficient. In case of insufficient knowledge on the dropout rate or ρ, a maximin strategy is devised: choose the design that minimizes the maximum variance of the treatment estimator. Such maximin designs are derived for each type of carry-over.

摘要

在考察治疗A与治疗B的效果时,在平行组设计、AA/BB设计、AB/BA交叉设计和巴兰设计之间可能存在选择。对于线性混合效应回归,从所涉及成本的灵活函数出发并考虑受试者退出的情况,考察哪种设计在估计这种效果时效率最高。对于无残留效应的情况,只要第二次测量时的退出率不超过2ρ/(1 + ρ)(ρ为组内相关系数),AB/BA交叉设计就是最有效的。对于稳态残留效应,根据所涉及的成本、退出率和ρ,平行设计或AA/BB设计可能是最有效的。对于允许自身残留效应的残留效应类型,关注的是直接治疗效果加上自身残留效应,此时AA/BB设计或巴兰设计是最有效的。在对退出率或ρ了解不足的情况下,设计了一种极大极小策略:选择使治疗估计量的最大方差最小化的设计。针对每种残留效应类型都推导出了此类极大极小设计。

相似文献

1
Parallel, AA/BB, AB/BA and Balaam's design: efficient and maximin choices when testing the treatment effect in a mixed effects linear regression.平行、AA/BB、AB/BA与巴兰设计:混合效应线性回归中检验治疗效果时的高效与极大极小选择
Pharm Stat. 2012 Mar-Apr;11(2):97-106. doi: 10.1002/pst.502. Epub 2012 Feb 15.
2
A powerful test for Balaam's design.对巴兰计划的有力考验。
Pharm Stat. 2015 Nov-Dec;14(6):464-70. doi: 10.1002/pst.1703. Epub 2015 Jul 27.
3
Maximin Efficiencies under Treatment-Dependent Costs and Outcome Variances for Parallel, AA/BB, and AB/BA Designs.平行设计、AA/BB设计和AB/BA设计在治疗相关成本和结果方差下的最大最小效率
Comput Math Methods Med. 2018 Oct 1;2018:8025827. doi: 10.1155/2018/8025827. eCollection 2018.
4
CrossOver: an algorithm for the construction of efficient cross-over designs.交叉设计:一种构建高效交叉设计的算法。
Stat Med. 2004 Sep 15;23(17):2645-58. doi: 10.1002/sim.1860.
5
Optimal crossover designs in the presence of carryover effects.存在残留效应时的最优交叉设计。
Biometrics. 1983 Dec;39(4):1087-91.
6
Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carry-over.合并平行和交叉临床试验的Meta分析。III:遗留问题
Stat Med. 2002 Aug 15;21(15):2161-73. doi: 10.1002/sim.1207.
7
An efficient design for a study comparing two drugs, their combination and placebo.一项用于比较两种药物、它们的组合以及安慰剂的研究的高效设计。
Stat Med. 2006 Jun 30;25(12):2043-58. doi: 10.1002/sim.2336.
8
The effect of dropout on the efficiency of D-optimal designs of linear mixed models.缺失值对线性混合模型D - 最优设计效率的影响。
Stat Med. 2008 Jun 30;27(14):2601-17. doi: 10.1002/sim.3108.
9
Two-period, two-treatment crossover designs subject to non-ignorable missing data.两周期、两处理交叉设计,存在不可忽略的缺失数据。
Biostatistics. 2013 Sep;14(4):626-38. doi: 10.1093/biostatistics/kxt009. Epub 2013 Mar 21.
10
Design and analysis of intra-subject variability in cross-over experiments.
Stat Med. 1996 Aug 15;15(15):1619-34. doi: 10.1002/(SICI)1097-0258(19960815)15:15<1619::AID-SIM326>3.0.CO;2-N.

引用本文的文献

1
Design, analysis, and interpretation of treatment response heterogeneity in personalized nutrition and obesity treatment research.个性化营养和肥胖治疗研究中治疗反应异质性的设计、分析和解释。
Obes Rev. 2023 Dec;24(12):e13635. doi: 10.1111/obr.13635. Epub 2023 Sep 4.
2
Maximin Efficiencies under Treatment-Dependent Costs and Outcome Variances for Parallel, AA/BB, and AB/BA Designs.平行设计、AA/BB设计和AB/BA设计在治疗相关成本和结果方差下的最大最小效率
Comput Math Methods Med. 2018 Oct 1;2018:8025827. doi: 10.1155/2018/8025827. eCollection 2018.